Best practice guidance for the use of strategies to improve retention in randomized trials developed from two consensus workshops

od Brueton, Valerie, Stenning, Sally P., Stevenson, Fiona, Tierney, Jayne, Rait, Greta
Izdano u J Clin Epidemiol (2017)

Assessing the potential for prevention or earlier detection of on-site monitoring findings from randomised controlled trials: Further analyses of findings from the prospective TEMP...

od Cragg, William J, Hurley, Caroline, Yorke-Edwards, Victoria, Stenning, Sally P
Izdano u Clin Trials (2020)

Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review

od Cragg, William J, Hurley, Caroline, Yorke-Edwards, Victoria, Stenning, Sally P
Izdano u Clin Trials (2021)

Implementing monitoring triggers and matching of triggered and control sites in the TEMPER study: a description and evaluation of a triggered monitoring management system

od Diaz-Montana, Carlos, Cragg, William J., Choudhury, Rahela, Joffe, Nicola, Sydes, Matthew R., Stenning, Sally P.
Izdano u Trials (2019)

Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide an...

od Cafferty, Fay H., White, Jeff D., Shamash, Jonathan, Hennig, Ivo, Stenning, Sally P., Huddart, Robert A.
Izdano u Eur J Cancer (2020)

Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched-pair study

od Stenning, Sally P, Cragg, William J, Joffe, Nicola, Diaz-Montana, Carlos, Choudhury, Rahela, Sydes, Matthew R, Meredith, Sarah
Izdano u Clin Trials (2018)

Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial

od Collins, Vincent Peter, Ichimura, Koichi, Di, Ying, Pearson, Danita, Chan, Ray, Thompson, Lindsay C, Gabe, Rhian, Brada, Michael, Stenning, Sally P
Izdano u Acta Neuropathol Commun (2014)

A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)

od Huddart, Robert A., Gabe, Rhian, Cafferty, Fay H., Pollock, Philip, White, Jeff D., Shamash, Jonathan, Cullen, Michael H., Stenning, Sally P.
Izdano u Eur Urol (2015)

Defining a New Prognostic index for Stage I Non-seminomatous Germ Cell Tumors using CXCL12 Expression and Proportion of Embryonal Carcinoma

od Gilbert, Duncan C, Al-Saadi, Reem, Thway, Khin, Chandler, Ian, Berney, Daniel, Gabe, Rhian, Stenning, Sally P, Sweet, Joan, Huddart, Robert, Shipley, Janet M
Izdano u Clin Cancer Res (2015)

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY1...

od Mead, Graham M., Barrans, Sharon L., Qian, Wendi, Walewski, Jan, Radford, John A., Wolf, Max, Clawson, Simon M., Stenning, Sally P., Yule, Claire L., Jack, Andrew S.
Izdano 2008

Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial

od Hale, Matthew D., Nankivell, Matthew, Hutchins, Gordon G., Stenning, Sally P., Langley, Ruth E., Mueller, Wolfram, West, Nicholas P., Wright, Alexander I., Treanor, Darren, Hewitt, Lindsay C., Allum, William H., Cunningham, David, Hayden, Jeremy D., Grabsch, Heike I.
Izdano u Oncotarget (2016)

Technical Reproducibility of Single-Nucleotide and Size-Based DNA Biomarker Assessment Using DNA Extracted from Formalin-Fixed, Paraffin-Embedded Tissues

od Zhang, Shenli, Tan, Iain B., Sapari, Nur S., Grabsch, Heike I., Okines, Alicia, Smyth, Elizabeth C., Aoyama, Toru, Hewitt, Lindsay C., Inam, Imran, Bottomley, Dan, Nankivell, Matthew, Stenning, Sally P., Cunningham, David, Wotherspoon, Andrew, Tsuburaya, Akira, Yoshikawa, Takaki, Soong, Richie, Tan, Patrick
Izdano u J Mol Diagn (2015)

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, o...

od Cunningham, David, Stenning, Sally P, Smyth, Elizabeth C, Okines, Alicia F, Allum, William H, Rowley, Sam, Stevenson, Laura, Grabsch, Heike I, Alderson, Derek, Crosby, Thomas, Griffin, S Michael, Mansoor, Wasat, Coxon, Fareeda Y, Falk, Stephen J, Darby, Suzanne, Sumpter, Kate A, Blazeby, Jane M, Langley, Ruth E
Izdano u Lancet Oncol (2017)

Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration

od Olson, Thomas A., Murray, Matthew J., Rodriguez-Galindo, Carlos, Nicholson, James C., Billmire, Deborah F., Krailo, Mark D., Dang, Ha M., Amatruda, James F., Thornton, Claire M., Arul, G. Suren, Stoneham, Sara J., Pashankar, Farzana, Stark, Daniel, Shaikh, Furqan, Gershenson, David M., Covens, Allan, Hurteau, Jean, Stenning, Sally P., Feldman, Darren R., Grimison, Peter S., Huddart, Robert A., Sweeney, Christopher, Powles, Thomas, Lopes, Luiz Fernando, dos Santos Agular, Simone, Chinnaswamy, Girish, Khaleel, Sahar, Abouelnaga, Sherif, Hale, Juliet P., Frazier, A. Lindsay
Izdano u J Clin Oncol (2015)

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

od Joffe, Johnathan K., Cafferty, Fay H., Murphy, Laura, Rustin, Gordon J.S., Sohaib, Syed A., Gabe, Rhian, Stenning, Sally P., James, Elizabeth, Noor, Dipa, Wade, Simona, Schiavone, Francesca, Swift, Sarah, Dunwoodie, Elaine, Hall, Marcia, Sharma, Anand, Braybrooke, Jeremy, Shamash, Jonathan, Logue, John, Taylor, Henry H., Hennig, Ivo, White, Jeff, Rudman, Sarah, Worlding, Jane, Bloomfield, David, Faust, Guy, Glen, Hilary, Jones, Rachel, Seckl, Michael, MacDonald, Graham, Sreenivasan, Thiagarajan, Kumar, Satish, Protheroe, Andrew, Venkitaraman, Ramachandran, Mazhar, Danish, Coyle, Victoria, Highley, Martin, Geldart, Tom, Laing, Robert, Kaplan, Richard S., Huddart, Robert A.
Izdano u J Clin Oncol (2022)